Rates* of reported cases† of acute hepatitis B, by state or jurisdiction — United States, 2021–2022
Source: CDC, National Notifiable Diseases Surveillance System.
* Rates per 100,000 population.
† Reported confirmed cases. For the case definition, see Acute Hepatitis B.
Only states with rates for 2021 and 2022 are shown. State/jurisdiction and year for no reported cases: Connecticut (2022, 2021), Hawaii (2022, 2021), New Mexico (2022).
State or jurisdiction ranked in decreasing order by the 2022 rate, 2021 rate, and then alphabetical order by name.
* Rates per 100,000 population.
† Reported confirmed cases. For the case definition, see Acute Hepatitis B.
Only states with rates for 2021 and 2022 are shown. State/jurisdiction and year for no reported cases: Connecticut (2022, 2021), Hawaii (2022, 2021), New Mexico (2022).
State or jurisdiction ranked in decreasing order by the 2022 rate, 2021 rate, and then alphabetical order by name.
During 2022, the rates of reported acute hepatitis B ranged from a high of 3.0 cases per 100,000 population in West Virginia to a low of 0.1 in Missouri, Idaho, North Dakota, Alaska, and Rhode Island (not included in Figure 2.2). The largest absolute decrease in rates during 2021–2022 was observed in Tennessee (decrease of 0.4 cases per 100,000 population), whereas the largest absolute increase was observed in Florida (increase of 0.5 cases per 100,000 population). With the varying availability of resources to conduct viral hepatitis surveillance and the relatively small number of acute hepatitis B cases reported in certain jurisdictions, wide fluctuations in annual rates might occur.
Hepatitis B figures and tables
- Figure 2.1. Number of reported cases and estimated infections of acute hepatitis B — United States, 2015–2022
- Figure 2.2. Rates of reported cases of acute hepatitis B, by state or jurisdiction — United States, 2021–2022
- Figure 2.3. Rates of reported cases of acute hepatitis B, by state or jurisdiction — United States, 2022
- Figure 2.4. Rates of reported cases of acute hepatitis B, by age group — United States, 2007–2022
- Figure 2.5. Rates of reported cases of acute hepatitis B, by sex — United States, 2007–2022
- Figure 2.6. Rates of reported cases of acute hepatitis B, by race/ethnicity — United States, 2007–2022
- Figure 2.7. Availability of information on risk behaviors or exposures associated with reported cases of acute hepatitis B — United States, 2022
- Figure 2.8. Rates of deaths with hepatitis B listed as a cause of death among residents, by state or jurisdiction — United States, 2022
- Table 2.1. Numbers and rates of reported cases of acute hepatitis B, by state or jurisdiction — United States, 2018–2022
- Table 2.2. Numbers and rates of reported cases of acute hepatitis B, by demographic characteristics — United States, 2018–2022
- Table 2.3. Reported risk behaviors or exposures among reported cases of acute hepatitis B — United States, 2022
- Table 2.4. Number of newly reported cases of perinatal hepatitis B, by state or jurisdiction — United States, 2022
- Table 2.5. Number and rate of newly reported cases of chronic hepatitis B, by state or jurisdiction — United States, 2022
- Table 2.6. Number and rate of newly reported cases of chronic hepatitis B, by demographic characteristics — United States, 2022
- Table 2.7. Numbers and rates of deaths with hepatitis B listed as a cause of death among residents, by state or jurisdiction — United States, 2018–2022
- Table 2.8. Numbers and rates of deaths with hepatitis B listed as a cause of death among residents, by demographic characteristics — United States, 2018–2022